Wird geladen...
The Place of PET to Assess New Therapeutic Effectiveness in Neurodegenerative Diseases
In vivo exploration of neurodegenerative diseases by positron emission tomography (PET) imaging has matured over the last 20 years, using dedicated radiopharmaceuticals targeting cellular metabolism, neurotransmission, neuroinflammation, or abnormal protein aggregates (beta-amyloid and intracellular...
Gespeichert in:
| Veröffentlicht in: | Contrast Media Mol Imaging |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Hindawi
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5985069/ https://ncbi.nlm.nih.gov/pubmed/29887768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/7043578 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|